
Telmostic AH 40mg/5mg/12.5mg Tablet
Marketer
Genostic Pharma Private Limited
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmostic AH 40mg/5mg/12.5mg Tablet
Amlodipine/Hydrochlorothiazide/Olmesartan 40mg/5mg/12.5mg tablets are a triple-drug formulation for managing hypertension when monotherapy proves insufficient. This medication lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Administer this medication with or without food, at the same time daily, as prescribed. Continue treatment as directed by your physician. The formulation includes a diuretic, increasing urination; therefore, avoid dosing within four hours of bedtime. Consistent use, even during periods of well-being, is crucial for optimal benefit, as hypertension often presents asymptomatically. Discontinuing treatment elevates the risk of cardiovascular events. Common side effects may encompass headache, lightheadedness, lethargy, altered taste perception, malaise, influenza-like symptoms, diarrhea, and sinus inflammation. Report any persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to alleviate potential dehydration symptoms such as muscle weakness, dry mouth, and excessive thirst. Prior to commencing treatment, disclose any pre-existing liver or kidney conditions, and seek medical counsel if pregnant or breastfeeding. Inform your physician of all concurrent medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, kidney function, electrolyte balance, and blood glucose levels is essential to ensure therapeutic efficacy.
Uses of Telmostic AH 40mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Telmostic AH 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmostic AH 40mg/5mg/12.5mg Tablet whole; do not damage it by chewing, crushing, or breaking. This medication can be administered with or without food, although consistent timing is recommended.
Common Side effects of Telmostic AH 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmostic AH 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the 40mg/5mg/12.5mg Telmostic AH tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, although consistent timing is recommended.
How Telmostic AH 40mg/5mg/12.5mg Tablet works:
A single Telmostic AH 40mg/5mg/12.5mg tablet contains telmisartan, amlodipine, and hydrochlorothiazide. Telmisartan, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both act to dilate blood vessels, thus reducing blood pressure. Hydrochlorothiazide, a diuretic, facilitates the excretion of excess fluid and electrolytes via urination, contributing to vasodilation and improved circulation over time.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telmostic AH 40mg/5mg/12.5mg tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Use of Telmostic AH 40mg/5mg/12.5mg tablets is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Telmostic AH 40mg/5mg/12.5mg tablets while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by Telmostic AH 40mg/5mg/12.5mg Tablets, due to potential side effects including dizziness, headache, nausea, or fatigue. These side effects can reduce concentration and thus impact driving safety.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telmostic AH 40mg/5mg/12.5mg Tablets. Dosage modification may be necessary; physician consultation is advised. Telmostic AH 40mg/5mg/12.5mg Tablets are generally unsuitable for individuals with severe kidney disease.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Telmostic AH 40mg/5mg/12.5mg tablets. Dosage modification of Telmostic AH 40mg/5mg/12.5mg tablets may be necessary. A physician's consultation is recommended.
What if you forget to take Telmostic AH 40mg/5mg/12.5mg Tablet :
Should you forget a Telmostic AH 40mg/5mg/12.5mg Tablet dose, take it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmostic AH 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
